Advertisement

Banner Bruker Daltonik GmbH amaZon speed Mass Spectrometer Trade-In 600x60px
Financing › Details

PerkinElmer–SEVERAL: credit, 201110–2021 $500m 5.00% Senior Notes due 2021 at issue price of 99.372% of principal amount

 

Period Period 2011-10-21 — 2021-01-01
Organisation Money taker PerkinElmer Inc. (NYSE: PKI)
  Group PerkinElmer (Group)
Product Product laboratory equipment and instruments
  Index term 2 Caliper–PerkinElmer: investment, 201109 acquisition $600m in cash $10.5/share announced
     

PerkinElmer, Inc.. (10/21/11). "Press Release: PerkinElmer Prices Offering of Senior Notes". Waltham, MA.

PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, announced today that it has priced an offering of $500,000,000 aggregate principal amount of 5.00% senior notes due 2021 at an issue price of 99.372% of the principal amount.

The issuance of the notes is expected to close on October 25, 2011. The notes will pay interest on a semi-annual basis.

The company plans to use the proceeds of the offering to fund, in part, the company's acquisition of Caliper Life Sciences, Inc. (NASDAQ: CALP). The aggregate purchase price of the Caliper acquisition is estimated to be approximately $600 million net of acquired cash. The Caliper acquisition has been separately announced by the company.

The joint book-running managers for the offering are Merrill Lynch, Pierce, Fenner & Smith Incorporated, Barclays Capital Inc. and Deutsche Bank Securities Inc.

PerkinElmer has filed a registration statement on Form S-3 (including a prospectus) with the Securities and Exchange Commission (the "SEC"). Prospective investors should read the prospectus forming a part of that registration statement and the preliminary prospectus supplement related to the offering and the other documents that the company has filed with the SEC for more complete information about the company and this offering. These documents are available at no charge by visiting EDGAR on the SEC Website at www.sec.gov. Alternatively, these documents will be made available upon request by the company or by any underwriter or dealer participating in the offering. Interested parties may obtain a prospectus or the related preliminary prospectus supplement from Merrill Lynch, Pierce, Fenner & Smith Incorporated by directing a request to dg.prospectus_requests@baml.com, or by calling 1-800-294-1322; or from Barclays Capital Inc. by directing a request to Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, New York, NY 11717, or by calling 1-888-603-5847; or from Deutsche Bank Securities Inc. by directing a request to 100 Plaza One, Floor 2, Jersey City, NJ, 07311-3901, Attn: Prospectus Department, or via email at prospectus.cpdg@db.com, or by calling 1-800-503-4611.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy the notes, nor shall there be any offer, solicitation or sale of the notes in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.


About PerkinElmer, Inc.

PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $1.7 billion in 2010, has about 6,200 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

PerkinElmer, Inc.

Investor Relations:
David C. Francisco, 781-663-5677
Vice President, Investor Relations
dave.francisco@perkinelmer.com
or
Media Contacts:
Stephanie R. Wasco, 781-663-5701
Vice President, Corporate Communications
stephanie.wasco@perkinelmer.com
or
Mario Fante, 781-663-5602
Corporate Public Relations Manager
mario.fante@perkinelmer.com

Source: PerkinElmer, Inc.

   
Record changed: 2011-11-25

More documents for PerkinElmer (Group)


To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com






» top

Advertisements

Banner Ionicon Analytik GmbH High-Resolution VOC-Monitoring PTR-MS 120x120px Banner Sage-N Reseearch at ASMS 2012 Sorcerer MS/MS Data Analysis 120x120px Banner Bruker Daltonik GmbH amaZon speed Mass Spectrometer Trade-In 120x120px Banner Dichrom GmbH Protea GPR 800 Protein Recovery System 120x120px Banner Nordantec GmbH Analytical Instruments Chromatography 120x54px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Banner [iiito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px